Jazz Pharmaceuticals JAZZ Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's deferred tax assets and other non-current assets?
- Jazz Pharmaceuticals (JAZZ) reported deferred tax assets and other non-current assets of $94.7M in Q1 2026.
- How has Jazz Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?
- Jazz Pharmaceuticals's deferred tax assets and other non-current assets decreased by 18.7% year-over-year, from $116.52M to $94.7M.
- What is the long-term trend for Jazz Pharmaceuticals's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's deferred tax assets and other non-current assets has grown at a 30.9% compound annual growth rate (CAGR), from $25.72M to $99M.